FDA Publishes Guidance on Clinical Trials for GERD in Children

Clinical Trials Advisor
The FDA issued a new draft guidance for sponsors developing treatments for gastroesophageal reflux disease in infants, children and adolescents — outlining clinical trial design considerations and the agency’s current thinking on extrapolating data in pediatrics.

To View This Article:


Subscribe To Clinical Trials Advisor